AORT.NYSEArtivion, INC

SCHEDULE 13G/A: Perceptive Advisors Amends Artivion Stake to 4.3%

Sentiment:

Beneficial Ownership Report


Perceptive Advisors and related entities have filed an amendment to their Schedule 13G, disclosing a 4.3% beneficial ownership in Artivion, Inc. common stock.

Summary

  • Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Artivion, Inc.
  • The Reporting Persons collectively beneficially own 2,020,000 shares of Artivion, Inc. Common Stock.
  • This represents 4.3% of the outstanding class of Artivion, Inc. Common Stock.
  • The ownership percentage is based on 47,374,939 outstanding shares as of October 31, 2025, as reported in Artivion's Form 10-Q filed on November 7, 2025.
  • Perceptive Advisors serves as the investment manager to the Master Fund, and Mr. Edelman is the managing member of Perceptive Advisors, leading to shared voting and dispositive power over the shares.

Sentiment

Score: 5

Explanation: This is a factual disclosure of beneficial ownership, not containing information that inherently drives strong positive or negative sentiment.

Future Outlook

NA

Industry Context

This filing reflects a routine disclosure by an institutional investment manager, Perceptive Advisors, regarding its stake in a publicly traded company, Artivion, Inc. Such disclosures are common in the investment industry, providing transparency on significant holdings by large funds.

Stakeholder Impact

  • Shareholders: Provides transparency regarding the beneficial ownership stake held by Perceptive Advisors and related entities, which can influence investor perception and trading decisions.

Key Dates

DateDescription
09/30/2025Date of event requiring the filing of this statement.
10/31/2025Date for outstanding shares calculation, as reported in Issuer's 10-Q.
11/07/2025Date Artivion, Inc. filed its Quarterly Report on Form 10-Q.
11/14/2025Date of signing and filing of this Schedule 13G Amendment No. 1.

Keywords

Artivion Inc., Perceptive Advisors, Joseph Edelman, Perceptive Life Sciences Master Fund, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, Institutional Investor

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.